Design of High-Affinity Mini-Protein Drug Conjugates Targeting TROP2
Journal of Medicinal Chemistry · 11.11.2026
DOI: 10.1021/acs.jmedchem.6c02191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 11.11.2026. Verfasst von Tianshui Xue und 8 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Accurate and effective treatment of solid tumors has long been a core issue in cancer therapy. Antibody-drug conjugates (ADCs) represent a crucial breakthrough in precision oncology. Traditional ADCs rely on monoclonal antibodies generated through animal immunization, followed by screening, sequencing, and recombinant expressiona process that is experimentally complex and costly. In this study, we employed deep learning-based computational design methods to design mini-protein binders targeting the tumor-associated antigen TROP2. The designed TROP2 mini-protein binder exhibited high specificity and thermal stability. The binding affinity was optimized from 40.4 nM to 628 pM through partial diffusion. On this basis, we engineered the mini-protein binder by conjugating it with the microtubule inhibitor VcMMAE, thereby constructing mini-protein drug conjugates (MPDCs) that can specifically target and kill TROP2-positive tumor cells. A comprehensive assessment of the anti-tumor efficacy of these MPDCs was performed using cancer cell lines, organoid models, and mouse xenograft models.
Förderung
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Young Talent of Lifting Engineering for Science and Technology in Shandong, China
Zitieren
APA
Xue, T., Li, N., Yang, Z., Tang, J., Ding, Y., Pan, J., Ju, Z., Wang, N., & Yu, B. (2026). Design of High-Affinity Mini-Protein Drug Conjugates Targeting TROP2. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02191
Vancouver
Xue T, Li N, Yang Z, Tang J, Ding Y, Pan J, et al. Design of High-Affinity Mini-Protein Drug Conjugates Targeting TROP2. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c02191
BibTeX
@article{Xue2026,
author = {Xue, Tianshui and Li, Na and Yang, Zhizhou and Tang, Jinbao and Ding, Yanhong and Pan, Jinheng and Ju, Zhenyu and Wang, Ningning and Yu, Bowen},
title = {Design of High-Affinity Mini-Protein Drug Conjugates Targeting TROP2},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02191}
}
EUVIMED